High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis

BACKGROUND: High-dose proton beam therapy (PBT) uses excellent dose concentricity based on the unique characteristic termed the Bragg peak. PBT is a highly feasible treatment option that improves survival in select patients with newly diagnosed glioblastoma (GBM). However, selection bias remains an...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Masahide, Mizumoto, Masashi, Kohzuki, Hidehiro, Sugii, Narushi, Sakurai, Hideyuki, Ishikawa, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948305/
https://www.ncbi.nlm.nih.gov/pubmed/36823671
http://dx.doi.org/10.1186/s13014-023-02236-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948305/
https://www.ncbi.nlm.nih.gov/pubmed/36823671
http://dx.doi.org/10.1186/s13014-023-02236-1

Ejemplares similares